Indegene Ltd

Indegene Ltd’s stock price plummeted 4% on June 4, 2025, amidst a flurry of block trades worth ₹3,480 crore, sparking concerns about investor confidence and the company’s ability to navigate market challenges.

Indegene Limited is set to release its quarterly financial results, with analysts expecting a 28.79% increase in earnings per share, reflecting the company’s strong performance and strategic initiatives in the life sciences industry.